News Industry News Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified November 08, 2011
News Industry News Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events November 08, 2011
News Industry News Bayer cooperates with Ludwig Boltzmann Institute for Translational Heart Failure Research November 08, 2011
News Industry News Edwards Receives FDA Approval to Expand U.S. Clinical Trial of Next-Generation Transcatheter Valve November 06, 2011
News Industry News Cardiac Dimensions Announces Presentation of Two-Year Efficacy Data From TITAN Clinical Trial November 06, 2011
News Industry News Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011 November 04, 2011
News Industry News FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation November 04, 2011
News Industry News Abbott to Present New Data for Key Vascular Products at TCT 2011 November 03, 2011
News Industry News Boston Scientific Announces Schedule of Events at TCT Scientific Symposium November 01, 2011
News Industry News FDA Advisory Panel Makes Recommendation on Investigational Medtronic Phased RF Ablation System for Treatment of Persistent or Long-Standing Persistent Atrial Fibrillation October 27, 2011
News Industry News Medtronic Announces Results From TTOP-AF Trial Demonstrating Clinical Benefits of Its Phased RF Ablation System in Treating Persistent Atrial Fibrillation October 10, 2011
News Industry News St. Jude Medical Announces European Launch of Smaller Quadripolar Pacing System September 20, 2011
News Industry News FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation September 08, 2011
News Industry News Medtronic Gains CE Mark for 31mm CoreValve® Percutaneous Aortic Valve August 18, 2011
News Industry News Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study August 15, 2011
News Industry News Abbott Receives U.S. FDA Approval for RX Herculink Elite® Renal Stent System for Treatment of Renal Artery Disease August 10, 2011
News Industry News Enrollment at St. John's Hospital Marks Official Start of the Largest Randomized Peripheral Drug-Coated Balloon Trial To Date July 25, 2011